Suppr超能文献

相似文献

1
Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis.
J Zhejiang Univ Sci B. 2020;21(2):122-136. doi: 10.1631/jzus.B1900422. Epub 2020 Feb 5.
3
High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
Oncotarget. 2017 May 30;8(22):36185-36202. doi: 10.18632/oncotarget.15873.
4
PTBP1 as a potential regulator of disease.
Mol Cell Biochem. 2024 Nov;479(11):2875-2894. doi: 10.1007/s11010-023-04905-x. Epub 2023 Dec 22.
5
Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines.
Brain. 2009 Aug;132(Pt 8):2277-88. doi: 10.1093/brain/awp153. Epub 2009 Jun 8.
6
Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D2.
J Neurochem. 2011 Jan;116(1):76-81. doi: 10.1111/j.1471-4159.2010.07086.x. Epub 2010 Dec 2.
7
LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement.
J Exp Clin Cancer Res. 2023 Sep 23;42(1):246. doi: 10.1186/s13046-023-02827-6.
8
A Short Tandem Repeat-Enriched RNA Assembles a Nuclear Compartment to Control Alternative Splicing and Promote Cell Survival.
Mol Cell. 2018 Nov 1;72(3):525-540.e13. doi: 10.1016/j.molcel.2018.08.041. Epub 2018 Oct 11.
9
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.
Oncogene. 2016 Apr 21;35(16):2031-9. doi: 10.1038/onc.2015.270. Epub 2015 Aug 3.
10
PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
Biomed Pharmacother. 2018 Dec;108:194-200. doi: 10.1016/j.biopha.2018.09.031. Epub 2018 Sep 13.

引用本文的文献

3
5
PTBP1 and Cancer: From RNA Regulation to Therapeutic Potential.
J Cell Mol Med. 2025 Jul;29(13):e70675. doi: 10.1111/jcmm.70675.
6
Alternative Splicing and CaV-Associated Channelopathies.
Wiley Interdiscip Rev RNA. 2025 May-Jun;16(3):e70016. doi: 10.1002/wrna.70016.
7
PKM2-mediated metabolic reprogramming of microglia in neuroinflammation.
Cell Death Discov. 2025 Apr 6;11(1):149. doi: 10.1038/s41420-025-02453-5.
8
Inverted Alu repeats in loop-out exon skipping across hominoid evolution.
bioRxiv. 2025 Mar 10:2025.03.07.642063. doi: 10.1101/2025.03.07.642063.
9
Landscape of chimeric RNAs in COVID-19 patient blood.
Genes Dis. 2024 Jun 6;12(3):101348. doi: 10.1016/j.gendis.2024.101348. eCollection 2025 May.
10
Hsa_circ_0001756 drives gastric cancer glycolysis by increasing the expression and stability of PGK1 mRNA.
Front Immunol. 2025 Feb 20;16:1511247. doi: 10.3389/fimmu.2025.1511247. eCollection 2025.

本文引用的文献

1
Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia.
Int J Biol Sci. 2019 Mar 1;15(4):882-894. doi: 10.7150/ijbs.30290. eCollection 2019.
2
Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease.
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3389-3402. doi: 10.1210/jc.2019-00021.
3
CD19 CAR T cell product and disease attributes predict leukemia remission durability.
J Clin Invest. 2019 Mar 12;129(5):2123-2132. doi: 10.1172/JCI125423. Print 2019 May 1.
5
FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells.
Oncotarget. 2019 Jan 1;10(1):30-44. doi: 10.18632/oncotarget.26530.
7
CAR T cell therapy: inroads to response and resistance.
Nat Rev Immunol. 2019 Feb;19(2):73-74. doi: 10.1038/s41577-018-0119-y.
8
Ethical considerations of cellular immunotherapy for cancer.
J Zhejiang Univ Sci B. 2019;20(1):23-31. doi: 10.1631/jzus.B1800421.
9
NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
Oncogene. 2019 Apr;38(16):2937-2952. doi: 10.1038/s41388-018-0639-8. Epub 2018 Dec 19.
10
Developmental Xist induction is mediated by enhanced splicing.
Nucleic Acids Res. 2019 Feb 20;47(3):1532-1543. doi: 10.1093/nar/gky1198.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验